Literature DB >> 27081761

Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.

Xiaolei Lin1, Yiqun Huang1, Yong Zou1, Xingsheng Chen2, Xudong Ma1.   

Abstract

G9a is a mammalian histone methyltransferase that contributes to the epigenetic silencing of tumor suppressor genes. Evidence suggests that G9a is required to maintain the malignant phenotype, but little documentation show the role of G9a function in mediating tumor growth. We retrospectively analyzed the protein of G9a and monomethylated histone H3 lysine 9 (H3K9 me1), and dimethylated histone H3 lysine 9 (H3K9 me2) in 175 cases of gastric carcinoma by immunohistochemistry. RNAi-based inhibition of G9a in MGC803 cancer cell line was studied. G9a depletion was done by transient transfection using Lipofectamine 2000. Depletion efficiency of G9a was tested using real-time PCR and western blot analysis. Cell apoptosis and proliferation were detected by TUNEL assay and MTT, respectively. The proteins of H3K9 me1, me2, trimethylation of H3K9 (H3K9 me3), monomethylated histone H3 lysine 27 (H3K27 me1), dimethylated histone H3 lysine 27 (H3K27 me2) and histone acetylated H3, apoptotic proteins were studied by western blot analysis. G9a and H3K9 me2 expression was higher in gastric cancer cells compared to the control (p<0.05). Both G9a and H3K9 me2 were positively correlated with the degree of differentiation, depth of infiltration, lymphatic invasions and tumor-node-metastasis stage in gastric carcinoma, (p<0.05). RNAi-mediated knockdown of G9a induced cell apoptosis and inhibited cell proliferation. Depletion of G9a reduced the levels of H3K9 me1 and me2, H3K27 me1 and me2. Nonetheless, it did not activate acetylation of H3 and H3K9 me3. These data suggest that G9a is required in tumorigenesis, and correlated with prognosis. Furthermore, G9a plays a critical role in regulating epigenetics. Depletion of G9a inhibits cell growth and induces cells apoptosis in gastric cancer. It might be of therapeutic benefit in gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27081761     DOI: 10.3892/or.2016.4692

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.

Authors:  Juliana Carvalho Alves-Silva; Juliana Lott de Carvalho; Doralina Amaral Rabello; Teresa Raquel Tavares Serejo; Eduardo Magalhaes Rego; Francisco Assis Rocha Neves; Antonio Roberto Lucena-Araujo; Fábio Pittella-Silva; Felipe Saldanha-Araujo
Journal:  Invest New Drugs       Date:  2018-05-31       Impact factor: 3.850

2.  Euchromatic histone lysine methyltransferase 1 regulates cancer development in human gastric cancer by regulating E-cadherin.

Authors:  Yao Yang; Jianfeng Shen; Dongyi Yan; Biao Yuan; Shun Zhang; Jing Wei; Tao Du
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

Review 3.  Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression.

Authors:  Nirmalya Saha; Andrew G Muntean
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-26       Impact factor: 10.680

4.  Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.

Authors:  Ai-Shun Guo; Yi-Qun Huang; Xu-Dong Ma; Rui-Sheng Lin
Journal:  Mol Med Rep       Date:  2016-10-06       Impact factor: 2.952

5.  G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.

Authors:  Lei Hu; Ming-de Zang; He-Xiao Wang; Bao-Gui Zhang; Zhen-Qiang Wang; Zhi-Yuan Fan; Huo Wu; Jian-Fang Li; Li-Ping Su; Min Yan; Zhi-Qiang Zhu; Qiu-Meng Yang; Qiang Huang; Bing-Ya Liu; Zheng-Gang Zhu
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

6.  Histone modification dynamics as revealed by multicolor immunofluorescence-based single-cell analysis.

Authors:  Yoko Hayashi-Takanaka; Yuto Kina; Fumiaki Nakamura; Leontine E Becking; Yoichi Nakao; Takahiro Nagase; Naohito Nozaki; Hiroshi Kimura
Journal:  J Cell Sci       Date:  2020-07-21       Impact factor: 5.285

7.  Increased expression of EHMT2 associated with H3K9me2 level contributes to the poor prognosis of gastric cancer.

Authors:  Ping Chen; Qi Qian; Zhiyuan Zhu; Xiaohui Shen; Shenling Yu; Zhenghong Yu; Rui Sun; Yiping Li; Didi Guo; Hong Fan
Journal:  Oncol Lett       Date:  2020-06-05       Impact factor: 2.967

8.  Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma.

Authors:  Hongyi Liao; Xianbiao Xie; Yuanyuan Xu; Gang Huang
Journal:  Onco Targets Ther       Date:  2018-10-15       Impact factor: 4.147

9.  Upregulated expression of G9a is correlated with poor prognosis of gastric cancer patients.

Authors:  Chi Zhang; Shaozhong Wei; Junjie Hu; Zhiguo Xiong
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 10.  Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities.

Authors:  Matteo Canale; Andrea Casadei-Gardini; Paola Ulivi; Maria Arechederra; Carmen Berasain; Pier-Luigi Lollini; Maite G Fernández-Barrena; Matías A Avila
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.